Radiometric pyrazinamide susceptibility testing of mycobacterium tuberculosis
Tarrand, J.J.; Spicer, A.; Groschel, D.H.M.
Abstracts of the Annual Meeting of the American Society for Microbiology 83: C226
1983
ISSN/ISBN: 0094-8519
Accession: 029027043
PDF emailed within 1 workday: $29.90
Related References
Salfinger, M.; Reller, L.B.; Demchuk, B.; Johnson, Z.T. 1989: Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis Research in Microbiology 140(4-5): 301-309Tarrand, J.J.; Spicer, A.D.; Gröschel, D.H. 1986: Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 30(6): 852-855
Madison, B.; Gross, W.; George, I.; Sloutsky, A.; Washabaugh, G.; Robinson-Dunn, B.; Lipman, H.; Metchock, B.; Mazurek, G.; Ridderhof, J. 2002: Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis Journal of Clinical Microbiology 40(10): 3753-3756
Woodley, C.L.; Smithwick, R.W. 1988: Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg-yolk-enriched BACTEC 12A medium Antimicrobial Agents and ChemoTherapy 32(1): 125-127
Woodley, C.L.; Smithwick, R.W. 1987: Radiometric method for pyrazinamide susceptibility testing of mycobacterium tuberculosis using egg yolk enriched bactec 12a medium Abstracts of the Annual Meeting of the American Society for Microbiology 87: 136
Scarparo, C.; Ricordi, P.; Ruggiero, G.; Piccoli, P. 2004: Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method Journal of Clinical Microbiology 42(3): 1109-1114
Kontos, F.; Nicolaou, S.; Kostopoulos, C.; Gitti, Z.; Petinaki, E.; Maniati, M.; Anagnostou, S.; Raftopoulou, A.; Papageorgiou, P.; Scrioubellou, A.; Tselentis, I.; Maniatis, A.N. 2003: Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system Journal of Microbiological Methods 55(1): 331-333
Salfinger, M.; Kafader, F.M. 1987: Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Series A Medical Microbiology Infectious Diseases Virology Parasitology 265(3-4): 404-407
The Editors 2002: Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide Journal of Medical Microbiology 51(1): 11-12
Huang, Z.-K.; Luo, Q.; Jiang, B.-X.; Li, W.-T.; Xu, X.-M.; Xiong, G.-L.; Li, J.-M. 2013: Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis Chinese Medical Journal 126(22): 4334-4339
Zimic, M.; Loli, S.; Gilman, R.H.; Gutierrez, A.és.; Fuentes, P.; Cotrina, M.; Kirwan, D.; Sheen, P. 2012: A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis Microbial Drug Resistance 18(4): 372-375
Li, H.; Zhou, L.-P.; Luo, J.; Yu, J.-P.; Yang, H.; Wei, H.-P. 2016: Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 20(4): 462-467
Ashtekar, D.R.; Fernandes, F.; Kale, R.N.; Virde, B.S.; Khadse, B.G.; Devdhar, M.N.; Ganatra, R.D.; Shah, D.H.; Shirodkar, M.V.N.; Deshpande, V.R. 1985: Rapid indirect pyrazinamide susceptibility testing of mycobacterium tuberculosis IRCS (International Research Communications System) Medical Science 13(8): 736-737
Butler, W.R.; Kilburn, J.O. 1982: Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide Journal of Clinical Microbiology 16(6): 1106-1109
Heifets, L.; Sanchez, T. 2000: New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide Journal of Clinical Microbiology 38(4): 1498-1501